Name: S&P/ASX 300 Health Care Index Performance - Biotech Investor Club
Uploaded: 2020-03-10T20:23:48.000Z
Duration: 2 min 29 s
Description: Thousands of YouTube videos with English-Chinese subtitles! Now you can learn to understand native speakers, expand your vocabulary, and improve your pronunciation...

Adverbs of manner

And you can very clearly see that the healthcare space well and truly outstrips the overall broader market.

And it's not hard to understand why that's in the case.

Adverbs of degree

The 23 stocks inside that index have been very well supported and watching.

Only to look at is the channel is great, and quite clearly, if you have a look, it's up 21%.

But more importantly, is that what's come with that is the earnings growth behind it.

And you can see this on the chancellor of the total revenue generated over the last 12 months has been very strong.

In fact, it's touching the top end of that five year band.

You can also have a look at things like also the yield.

Your has fallen away, and that's actually a positive thing. 00:00:58.860 --> 00:01:1.680  That means that it is being bid up and beat up strongly. 00:01:1.680 --> 00:01:4.950  Health care is a growth industry and a very strong growth industry. 00:01:4.960 --> 00:01:13.700  That, and what was very strong over the last year and something that we were alluded to before is that the government spending in it at the moment is well and truly on the way up.

Have a look at the Medicare numbers that we saw over the last 12 months.

Each month has been increasing where that's across surgical, whether it's cross pathology and then also into the hospitals.

And that has been a generation movement we're seeing also on budget.

Whether you support left or right of the political divide does not matter.

GDP now sits a 10.8% in the health care space and is only going to expand that child again from the first part, shows you exactly why that is the case.

The other thing about the air 6 300 healthcare indexes, the broad base that has across the whole lifestyle spotters life science space really want to highlight a few of them?

Clear the fact of the biggest behemoth in there being CSL continues to put RND front and center. 00:01:58.310 --> 00:02:8.160  $645 million in R and D for this financial year alone is a major contributor y, but it's not the only space and the only stock in there. 00:02:8.160 --> 00:02:14.280  You could say that across the surgical proprietors, the pathology supplies, all inside that health space that are growing.

So what a year in Spain, I'll certainly be looking at doing the best and worst performance of the next coming weeks.

 But clearly the healthcare space continues to be inflation hedged, and kids used to be the gross base to bay. 